Anpeval (Triflusal)

Anpeval is a medication containing Triflusal, used for its antiplatelet properties. It is commonly prescribed to support cardiovascular health and prevent blood clot formation.

Anpeval, containing Triflusal, is primarily used to inhibit platelet aggregation, which helps in reducing the risk of blood clots. It is often recommended for individuals with cardiovascular conditions or those who have undergone certain surgical procedures. Triflusal is also used to manage conditions where preventing blood clots is crucial, such as in the treatment of ischemic stroke or peripheral arterial disease.

Anpeval may cause common side effects such as gastrointestinal discomfort, nausea, or mild headaches. Some users might experience dizziness or skin rashes. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Anpeval should be used with caution in individuals with a history of bleeding disorders or those currently taking other blood-thinning medications. It is important to follow the prescribed dosage and consult a healthcare professional before starting or stopping the medication. Pregnant or breastfeeding women should seek medical advice before using Anpeval.

Anpeval may interact with other medications, particularly those that affect blood clotting, such as anticoagulants or nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.